Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-144360
Filing Date
2022-05-09
Accepted
2022-05-09 08:15:59
Documents
1
Period of Report
2022-05-09

Document Format Files

Seq Description Document Type Size
1 6-K d296275d6k.htm 6-K 12377
  Complete submission text file 0001193125-22-144360.txt   13400
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 22903334
SIC: 2834 Pharmaceutical Preparations